TECAN GENOMICS, INC.

TECAN GENOMICS, INC. specializes in advanced biotechnological research and diagnostic reagent development, with a focus on molecular diagnostics, RNA sequencing, and biological material procurement for infectious disease surveillance. The contractor delivers critical support for pathogen variant identification, including SARS-CoV-2, through high-precision reagent supply and biological sample processing, demonstrating deep expertise in nucleic acid analysis, next-generation sequencing workflows, and biospecimen logistics. Their technical capabilities center on enabling high-throughput genomic research in public health settings, with demonstrated proficiency in RNA-based assays and molecular reagent formulation tailored for clinical and research laboratories. The company maintains a consistent relationship with the Department of Health and Human Services, providing essential biological materials and reagents for virology and genomics initiatives within HHS components such as the Vaccine Research Center. Their work supports federal efforts in infectious disease monitoring, genomic epidemiology, and biodefense preparedness, indicating a trusted role in mission-critical public health research operations. TECAN GENOMICS, INC. operates primarily within the biotechnology research and development domain, with core NAICS codes reflecting expertise in both general biotechnology (541711) and non-nano biotech applications (541714), alongside niche work in nanobiotechnology (541713). This positions them as a specialized provider of molecular tools and biological reagents for federal research programs focused on genomic characterization and pathogen detection. As a small business entity structured as 2L and headquartered in Redwood City, California, the company leverages its proximity to major biotech and research hubs to serve federal science agencies. While no government certifications are listed, their consistent performance on HHS contracts underscores reliability in delivering sensitive, time-sensitive biological materials under stringent regulatory and quality standards.